Logan Stone Capital’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113K Buy
+11,313
New +$113K 0.03% 129

Other funds holding DMII

Logan Stone Capital's DMII Position: Q1 2026 in Review

Logan Stone Capital opened a new position in Drugs Made In America Acquisition II Corp (DMII) in Q1 2026: 11,313 shares worth $113K. The stake represents 0.03% of the portfolio and ranks #129 among its holdings.

68 funds tracked by Wall St. Rank hold DMII as of Q1 2026.

  • Logan Stone Capital held 11,313 shares of Drugs Made In America Acquisition II Corp worth $113K as of Q1 2026.
  • Drugs Made In America Acquisition II Corp was a new Logan Stone Capital position in Q1 2026.
  • Drugs Made In America Acquisition II Corp made up 0.03% of Logan Stone Capital's portfolio in Q1 2026, its #129 holding.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q1 2026.

Based on Logan Stone Capital's 13F filing for Q1 2026, filed 15 May 2026.